189 related articles for article (PubMed ID: 21214253)
41. Cryptic and Stereospecific Hydroxylation, Oxidation, and Reduction in Platensimycin and Platencin Biosynthesis.
Dong LB; Zhang X; Rudolf JD; Deng MR; Kalkreuter E; Cepeda AJ; Renata H; Shen B
J Am Chem Soc; 2019 Mar; 141(9):4043-4050. PubMed ID: 30735041
[TBL] [Abstract][Full Text] [Related]
42. Stereoselective approach to the racemic oxatetracyclic core of platensimycin.
Horii S; Torihata M; Nagasawa T; Kuwahara S
J Org Chem; 2013 Mar; 78(6):2798-801. PubMed ID: 23373732
[TBL] [Abstract][Full Text] [Related]
43. Late-Stage Functionalization of Platensimycin Leading to Multiple Analogues with Improved Antibacterial Activity in Vitro and in Vivo.
Deng Y; Weng X; Li Y; Su M; Wen Z; Ji X; Ren N; Shen B; Duan Y; Huang Y
J Med Chem; 2019 Jul; 62(14):6682-6693. PubMed ID: 31265289
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450-Catalyzed Hydroxylation Initiating Ether Formation in Platensimycin Biosynthesis.
Rudolf JD; Dong LB; Zhang X; Renata H; Shen B
J Am Chem Soc; 2018 Oct; 140(39):12349-12353. PubMed ID: 30216060
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and antibacterial properties of (-)-nor-platencin.
Barykina OV; Rossi KL; Rybak MJ; Snider BB
Org Lett; 2009 Nov; 11(22):5334-7. PubMed ID: 19845392
[TBL] [Abstract][Full Text] [Related]
46. Total synthesis and antibacterial properties of carbaplatensimycin.
Nicolaou KC; Tang Y; Wang J; Stepan AF; Li A; Montero A
J Am Chem Soc; 2007 Dec; 129(48):14850-1. PubMed ID: 17988130
[TBL] [Abstract][Full Text] [Related]
47. Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation.
Chen Y; Smanski MJ; Shen B
Appl Microbiol Biotechnol; 2010 Mar; 86(1):19-25. PubMed ID: 20091304
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of platensimycin analogues and their antibiotic potency.
Krauss J; Knorr V; Manhardt V; Scheffels S; Bracher F
Arch Pharm (Weinheim); 2008 Jun; 341(6):386-92. PubMed ID: 18442030
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and biological evaluation of platensimycin analogues with varying degrees of molecular complexity.
Nicolaou KC; Stepan AF; Lister T; Li A; Montero A; Tria GS; Turner CI; Tang Y; Wang J; Denton RM; Edmonds DJ
J Am Chem Soc; 2008 Oct; 130(39):13110-9. PubMed ID: 18771264
[TBL] [Abstract][Full Text] [Related]
50. Total synthesis and antibiotic activity of dehydrohomoplatencin.
Waalboer DC; Leenders SH; Schülin-Casonato T; van Delft FL; Rutjes FP
Chemistry; 2010 Oct; 16(37):11233-6. PubMed ID: 20715217
[No Abstract] [Full Text] [Related]
51. Platensimycin and platencin biosynthesis in Streptomyces platensis, showcasing discovery and characterization of novel bacterial diterpene synthases.
Smanski MJ; Peterson RM; Shen B
Methods Enzymol; 2012; 515():163-86. PubMed ID: 22999174
[TBL] [Abstract][Full Text] [Related]
52. Titer improvement and pilot-scale production of platensimycin from Streptomyces platensis SB12026.
Shi J; Pan J; Liu L; Yang D; Lu S; Zhu X; Shen B; Duan Y; Huang Y
J Ind Microbiol Biotechnol; 2016 Jul; 43(7):1027-35. PubMed ID: 27126098
[TBL] [Abstract][Full Text] [Related]
53. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
[TBL] [Abstract][Full Text] [Related]
54. Syntheses and antibacterial properties of iso-platencin, Cl-iso-platencin and Cl-platencin: identification of a new lead structure.
Tiefenbacher K; Gollner A; Mulzer J
Chemistry; 2010 Aug; 16(31):9616-22. PubMed ID: 20486112
[TBL] [Abstract][Full Text] [Related]
55. Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis.
Smanski MJ; Yu Z; Casper J; Lin S; Peterson RM; Chen Y; Wendt-Pienkowski E; Rajski SR; Shen B
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13498-503. PubMed ID: 21825154
[TBL] [Abstract][Full Text] [Related]
56. Strain prioritization for natural product discovery by a high-throughput real-time PCR method.
Hindra ; Huang T; Yang D; Rudolf JD; Xie P; Xie G; Teng Q; Lohman JR; Zhu X; Huang Y; Zhao LX; Jiang Y; Duan Y; Shen B
J Nat Prod; 2014 Oct; 77(10):2296-303. PubMed ID: 25238028
[TBL] [Abstract][Full Text] [Related]
57. Structures of Pseudomonas aeruginosa β-ketoacyl-(acyl-carrier-protein) synthase II (FabF) and a C164Q mutant provide templates for antibacterial drug discovery and identify a buried potassium ion and a ligand-binding site that is an artefact of the crystal form.
Baum B; Lecker LS; Zoltner M; Jaenicke E; Schnell R; Hunter WN; Brenk R
Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):1020-6. PubMed ID: 26249693
[TBL] [Abstract][Full Text] [Related]
58. 7-Phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycin.
Jang KP; Kim CH; Na SW; Jang DS; Kim H; Kang H; Lee E
Bioorg Med Chem Lett; 2010 Apr; 20(7):2156-8. PubMed ID: 20207542
[TBL] [Abstract][Full Text] [Related]
59. A bifunctional Lewis acid induced cascade cyclization to the tricyclic core of ent-kaurenoids and its application to the formal synthesis of (±)-platensimycin.
Zhu L; Han Y; Du G; Lee CS
Org Lett; 2013 Feb; 15(3):524-7. PubMed ID: 23327558
[TBL] [Abstract][Full Text] [Related]
60. A new route to platencin via decarboxylative radical cyclization.
Moustafa GA; Saku Y; Aoyama H; Yoshimitsu T
Chem Commun (Camb); 2014 Dec; 50(99):15706-9. PubMed ID: 25361063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
